Alterity Therapeutics (PRNAD) Change in Receivables (2009 - 2020)

Alterity Therapeutics (PRNAD) has reported Change in Receivables for 10 consecutive years, with $898621.0 the latest figure, recorded in Q2 2020.

• In Q2 2020, Change in Receivables rose 176.49% year-over-year to $898621.0; the TTM figure through Jun 2020 stood at -$542814.8 (up 15.57% YoY), while the FY2025 annual figure was $66648.6, down 97.81% from the prior year.
• Change in Receivables came in at $898621.0 for Q2 2020 at Alterity Therapeutics, up from -$2.0 million in the prior quarter.
• The five-year high for Change in Receivables was $1.7 million in Q4 2018, with the low at -$2.2 million in Q4 2016.
• Average Change in Receivables over 5 years is -$150911.9, with a median of -$884.5 recorded in 2018.
• Across the five-year window, Change in Receivables surged 243.82% in 2018 and slumped 132715.6% in 2019, its largest moves.
• Year by year, Change in Receivables stood at -$2.2 million in 2016, then soared by 44.88% to -$1.2 million in 2017, then soared by 243.82% to $1.7 million in 2018, then slumped by 215.25% to -$2.0 million in 2019, then soared by 144.59% to $898621.0 in 2020.
• According to Business Quant data, Change in Receivables over the past three periods registered $898621.0, -$2.0 million, and -$1.2 million for Q2 2020, Q4 2019, and Q2 2019 respectively.